Clinical Trial: IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational
Official Title: An Epidemiologic, Descriptive and Cross-sectional Study of the IGF-1, IGFBP-3 and ALS Normative Ranges in a Healthy Paediatric Spanish Population, Divided Into Chronological Age, Sex and Pubertal Stag
Brief Summary: To determine the normative ranges of the Insulin-like Growth Factor 1 (IGF-1), Insulin-like growth factor-binding protein 3 (IGFBP-3), Acid-Labile Subunit (ALS) according to age, sex and pubertal stage of a healthy paediatric Spanish population.
Detailed Summary:
Sponsor: Ipsen
Current Primary Outcome: IGF-1 levels according to age, sex and pubertal stage in healthy paediatric volunteers [ Time Frame: At the time of participant's single study visit (day 1) ]
Original Primary Outcome: IGF-1 levels according to age, sex and pubertal stage of the healthy paediatric volunteers [ Time Frame: At the time of participant's single study visit (day 1) ]
Current Secondary Outcome:
- IGFBP-3 levels according to age, sex and pubertal stage in healthy paediatric volunteers [ Time Frame: At the time of participant's single study visit (day 1) ]
- ALS levels according to age, sex and pubertal stage in healthy paediatric volunteers [ Time Frame: At the time of participant's single study visit (day 1) ]
Original Secondary Outcome:
- IGFBP-3 according to age, sex and pubertal stage of the healthy paediatric volunteers [ Time Frame: At the time of participant's single study visit (day 1) ]
- ALS levels according to age, sex and pubertal stage of the healthy paediatric volunteers [ Time Frame: At the time of participant's single study visit (day 1) ]
Information By: Ipsen
Dates:
Date Received: August 22, 2012
Date Started: July 2012
Date Completion:
Last Updated: December 19, 2013
Last Verified: December 2013
